Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Components - Breakdown of the Company Revenue (Details)

v3.22.2
Balance Sheet Components - Breakdown of the Company Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Concentration Risk [Line Items]        
Revenues $ 103,376 $ 101,563 $ 183,761 $ 188,495
U.S. revenue        
Concentration Risk [Line Items]        
Revenues 65,935 79,740 118,379 150,952
Non-U.S. revenue        
Concentration Risk [Line Items]        
Revenues $ 37,441 $ 21,823 $ 65,382 $ 37,543